| Title |
Aging, Antiretrovirals, and Adherence: A Meta Analysis of Adherence among Older HIV-Infected Individuals
|
|---|---|
| Published in |
Drugs & Aging, August 2013
|
| DOI | 10.1007/s40266-013-0107-7 |
| Pubmed ID | |
| Authors |
Luwam Ghidei, Mark J. Simone, Marci J. Salow, Kristin M. Zimmerman, Allison M. Paquin, Lara M. Skarf, Tia R. M. Kostas, James L. Rudolph |
| Abstract |
Older adults are generally considered to be at greater risk for medication non-adherence due to factors such as medication complexity, side effects, cost, and cognitive decline. However, this generalization may not apply to older adults with human immunodeficiency virus (HIV). Regardless of age, suboptimal adherence to antiretroviral therapy (ART) can lead to increased viral load, immunosuppression, drug-resistant viral strains, co-morbidities, and opportunistic infections. Understanding trends of adherence to ART among older adults is critical, especially as the population of people living with HIV grows older. |
X Demographics
The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | 40% |
| United Kingdom | 1 | 20% |
| Canada | 1 | 20% |
| Singapore | 1 | 20% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 3 | 60% |
| Practitioners (doctors, other healthcare professionals) | 2 | 40% |
Mendeley readers
The data shown below were compiled from readership statistics for 175 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 1 | <1% |
| Unknown | 174 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 34 | 19% |
| Researcher | 29 | 17% |
| Student > Ph. D. Student | 18 | 10% |
| Student > Bachelor | 17 | 10% |
| Student > Doctoral Student | 11 | 6% |
| Other | 26 | 15% |
| Unknown | 40 | 23% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 53 | 30% |
| Nursing and Health Professions | 22 | 13% |
| Social Sciences | 15 | 9% |
| Psychology | 10 | 6% |
| Pharmacology, Toxicology and Pharmaceutical Science | 6 | 3% |
| Other | 21 | 12% |
| Unknown | 48 | 27% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 September 2013.
All research outputs
#6,708,962
of 22,719,618 outputs
Outputs from Drugs & Aging
#452
of 1,193 outputs
Outputs of similar age
#58,187
of 198,610 outputs
Outputs of similar age from Drugs & Aging
#5
of 16 outputs
Altmetric has tracked 22,719,618 research outputs across all sources so far. This one has received more attention than most of these and is in the 70th percentile.
So far Altmetric has tracked 1,193 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.6. This one has gotten more attention than average, scoring higher than 61% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 198,610 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.
We're also able to compare this research output to 16 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 68% of its contemporaries.